NASCAR Champion Kyle Busch Dies at 41 from Pneumonia and Sepsis Family Confirms SpaceX OpenAI Anthropic Could Surpass Berkshire Hathaway in FirstDay Trading Value Polymarket Jim Cramer Highlights Xometrys Growth What It Signals for the Manufacturing Marketplace IREN Stock Surges After 16 Billion Dell Deal to Boost AI Infrastructure SpaceXs Starship Test Flight A Critical Milestone Ahead of Potential IPO Tulsi Gabbard Steps Down as Intelligence Chief to Care for Ailing Husband GSM Q1 2026 Earnings NarrowerThanExpected Loss Boosts Investor Sentiment Airship AI Holdings Inc AISP Q3 2025 Earnings EPS Misses Estimates by a Wide Margin Yet Stock Rallies CVBF Q1 2026 Earnings Modest EPS Miss Amid Stable Operating Environment DSGR Q1 2026 Earnings EPS Beats Estimates Stock Edges Lower Camden National Corporation CAC Q1 2026 Earnings EPS Beat Surprises Amid Regional Banking Headwinds NeuroOne Medical Technologies NMTC Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Continues to Invest in Development Varonis Systems VRNS Holds Steady Amid Minor Dip Key Levels in Focus Tevogen Bio Warrants Hold Flat at 004 as Support and Resistance Converge Fortune Brands Innovations FBIN Gains 175 Testing Resistance Near 40 Stem Inc STEM Slips 146 Amid Resistance Test Key Support at 96 in Focus Raytech Holding RAY Edges Higher as Shares Test Key Resistance Zone US Military Strikes in Iran Raise Geopolitical Tensions Oil Markets on Edge STAA Q1 2026 Earnings EPS Soars Past Estimates Stock Declines Despite Strong Beat Cadiz Inc Depositary Shares CDZIP Gain Ground as Stock Holds Above Key Support MPLX Q1 2026 Earnings EPS Misses Estimates Amid Operational Challenges Stock Gains 147 ANRO Q1 2026 Earnings Significant EPS Miss Highlights EarlyStage Development Costs EXPD Q1 2026 Earnings EPS Surges Past Estimates by 262 as Stock Slips 127 LMFA Q1 2026 Earnings WiderThanExpected Loss Sends Stock Higher Jefferies Financial Group Inc JEF Q1 2026 Earnings EPS Misses Estimates as Stock Slips GLW Q1 2026 Earnings EPS Beat Surprises Amid Disclosed Revenue Uncertainty Quantum Biopharma Ltd QNTM Q4 2025 Earnings Biotech Firm Reports Wider Loss Amid Lack of Revenue Visibility